41
Participants
Start Date
November 30, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
January 31, 2013
Avastin
Avastin, by intravenous infusion, 10 mg/kg every 14 days
Temozolomide
Oral temozolomide at 200 mg/m2 daily for 5 days
Irinotecan
Irinotecan, by intravenous infusion, every other week (dose dependent upon if taking enzyme-inducing anti-epileptic drugs or if a blood test indicates the patient has the UGT 1A1 polymorphism)
The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham
Collaborators (1)
Genentech, Inc.
INDUSTRY
Katy Peters
OTHER